Top Page
ASP Isotopes, Inc.
(NASDAQ:ASPI)
ASP Isotopes, Inc. (ASPI) vs. SPDR S&P 500 ETF (SPY)
ASP Isotopes, Inc. Business Overview & Revenue Model
ASP Isotopes, Inc. Earnings Call Summary
ASP Isotopes, Inc. Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 8.38M | 4.14M | 433.03K | 0.00 | 0.00 |
| Gross Profit | 1.93M | 1.60M | 138.97K | -72.57K | -19.38K |
| EBITDA | -106.65M | -31.58M | -16.14M | -4.87M | -2.59M |
| Net Income | -105.56M | -32.33M | -16.29M | -4.79M | -2.61M |
Balance Sheet | |||||
| Total Assets | 225.89M | 94.35M | 30.19M | 12.50M | 7.14M |
| Cash, Cash Equivalents and Short-Term Investments | 113.94M | 61.89M | 7.91M | 2.39M | 2.95M |
| Total Debt | 113.66M | 37.75M | 2.14M | 822.20K | 926.60K |
| Total Liabilities | 129.29M | 43.18M | 11.36M | 2.68M | 1.14M |
| Stockholders Equity | 74.07M | 47.90M | 16.30M | 9.82M | 6.00M |
Cash Flow | |||||
| Free Cash Flow | -33.96M | -28.07M | -7.74M | -7.41M | -3.57M |
| Operating Cash Flow | -23.69M | -16.70M | -5.41M | -2.94M | -577.69K |
| Investing Cash Flow | -38.63M | -11.37M | -2.45M | -4.47M | -2.99M |
| Financing Cash Flow | 125.15M | 82.53M | 13.39M | 6.64M | 6.50M |
ASP Isotopes, Inc. Technical Analysis
ASP Isotopes, Inc. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | $444.87M | 8.61 | 6.62% | 3.86% | -5.05% | 35.01% | |
58 Neutral | $624.48M | -804.72 | -0.13% | ― | 12.49% | 95.48% | |
57 Neutral | $691.29M | -2.14 | -18.65% | 8.03% | -7.81% | -334.15% | |
50 Neutral | $673.91M | -4.25 | -187.23% | ― | 147.78% | -137.42% | |
49 Neutral | $382.60M | -0.92 | -78.11% | ― | -9.75% | -386.63% | |
47 Neutral | $1.12B | -1.30 | ― | ― | -10.68% | 36.31% |
ASP Isotopes, Inc. Corporate Events
ASP Isotopes Inc. held its 2025 Annual Meeting of Stockholders on December 18, 2025, at which shareholders addressed director elections and the appointment of the company’s external auditor. At the meeting, stockholders re-elected two Class III directors, Sipho N. Maseko and Todd Wider, M.D., to serve until the 2028 annual meeting or until their successors are chosen, and ratified the appointment of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, reinforcing continuity in both board leadership and financial oversight for the company and its investors.
On December 18, 2025, ASP Isotopes Inc. confirmed that South Africa’s Takeover Regulation Panel had issued a compliance certificate for its scheme of arrangement to acquire all issued ordinary shares of Renergen Limited, under which Renergen shareholders would receive 0.09196 new ASP Isotopes shares for each Renergen share, allowing the transaction to proceed toward implementation. The timetable sets out key milestones through mid‑January 2026, including suspension and eventual termination of Renergen’s listings on the JSE, A2X and ASX, the listing and settlement of new ASP Isotopes shares to former Renergen shareholders in South Africa and Australia, and the handling of fractional cash entitlements, underscoring the complexity of the cross‑border settlement structure and marking a significant step in ASP Isotopes’ expansion via the full acquisition and delisting of Renergen.
ASP Isotopes Inc. announced that effective January 19, 2026, Paul Mann, the founder and Executive Chairman, will resume his role as Chief Executive Officer while continuing as Executive Chairman. Robert Ainscow, who served as Interim CEO during Mann’s medical leave, will remain as Chief Operating Officer. The company has not made any new contractual arrangements related to Mann’s re-appointment.
On November 7, 2025, Quantum Leap Energy LLC, a subsidiary of ASP Isotopes Inc., announced a Convertible Note Purchase Agreement to issue and sell $64.3 million in convertible promissory notes to accredited investors. The proceeds will be used to develop laser enrichment production facilities and for general corporate purposes. The offering, expected to close around November 17 or 18, 2025, will also see the automatic conversion of existing 2024 Convertible Notes into new 2025 Notes. This move positions QLE to enhance its operational capabilities and potentially impact its market standing.
On October 1, 2025, ASP Isotopes Inc. announced that Paul Mann, the founder, Chairman, and CEO, took a temporary leave of absence from his CEO duties for health reasons. In his absence, Robert Ainscow, the Chief Operating Officer, was appointed as Interim CEO while continuing his current duties. Mann will remain as Executive Chairman, focusing on the company’s leadership and strategic direction alongside Ainscow and the Board. The transition is expected to maintain the company’s operational stability and ensure continued communication with industry partners and stakeholders.
On August 29, 2025, Quantum Leap Energy LLC (QLE), a subsidiary of ASP Isotopes Inc., acquired a controlling interest in Skyline Builders Group Holding Limited (SKBL), a company listed on Nasdaq. This acquisition is part of QLE’s strategy to secure critical materials supply chains essential for U.S. security and QLE’s growth. The acquisition involved a purchase agreement with Supreme Development Holdings, the previous controlling shareholder, and a private placement that raised $17,775,000. This transaction allowed QLE to gain 79.14% of the voting power in SKBL, significantly enhancing its control and influence over the company.